(Q53759964)

19 May 2018

title

Study of prognostic predictors for non-small cell lung cancer. (English)

1 reference

19 May 2018

author name string

Fu XL

1

1 reference

19 May 2018

Zhu XZ

2

1 reference

19 May 2018

Shi DR

3

1 reference

19 May 2018

Xiu LZ

4

1 reference

19 May 2018

Wang LJ

5

1 reference

19 May 2018

Zhao S

6

1 reference

19 May 2018

Qian H

7

1 reference

19 May 2018

Lu HF

8

1 reference

19 May 2018

Xiang YB

9

1 reference

19 May 2018

Jiang GL

10

1 reference

19 May 2018

publication date

1 February 1999

1 reference

19 May 2018

published in

Lung Cancer

1 reference

19 May 2018

volume

23

1 reference

19 May 2018

issue

2

1 reference

19 May 2018

page(s)

143-152

1 reference

19 May 2018

Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2899%2900009-4

7 January 2021

Survival predictors in advanced non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2899%2900009-4

7 January 2021

Prognostic factors for survival in advanced non-small-cell lung cancer: univariate and multivariate analyses including recursive partitioning and amalgamation algorithms in 1,052 patients. The European Lung Cancer Working Party.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2899%2900009-4

7 January 2021

Prognostic factors for patients with advanced non-small cell lung cancer: univariate and multivariate analyses including recursive partitioning and amalgamation

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2899%2900009-4

7 January 2021

Pretreatment minimal staging and prognostic factors for non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2899%2900009-4

7 January 2021

Non-small cell lung cancer: clinical value of new biological predictors

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2899%2900009-4

7 January 2021

The trends in histological types of lung cancer during 1980-1988, Guangzhou, China.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2899%2900009-4

7 January 2021

Survival in early-stage non-small cell lung cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2899%2900009-4

7 January 2021

Clinical stage II non-small cell lung cancer treated with radiation therapy alone. The significance of clinically staged ipsilateral hilar adenopathy (N1 disease)

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2899%2900009-4

7 January 2021

Radiotherapy alone versus combined chemotherapy and radiotherapy in nonresectable non-small-cell lung cancer: first analysis of a randomized trial in 353 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2899%2900009-4

7 January 2021

Vascular invasion in non-small cell lung carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2899%2900009-4

7 January 2021

Prognostic significance of tumor proliferative fraction and DNA content in stage I non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2899%2900009-4

7 January 2021

Postoperative adjuvant chemotherapy in non-small cell lung cancer: prognostic value of DNA ploidy and post-recurrent survival

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2899%2900009-4

7 January 2021

Flow cytometric DNA content and clinical outcome in patients with non-small cell lung cancer given postoperative radiation therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2899%2900009-4

7 January 2021

Prognostic significance of the expression ofras oncogene product in non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2899%2900009-4

7 January 2021

C-erbB-2 expression and codon 12 K-ras mutations both predict shortened survival for patients with pulmonary adenocarcinomas.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2899%2900009-4

7 January 2021

Antigens, receptors and dominant oncogenes and the prognosis of non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2899%2900009-4

7 January 2021

Correlation of L-myc RFLP with metastasis, prognosis and multiple cancer in lung-cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2899%2900009-4

7 January 2021

Overexpression of the c-erbB-2/neu-encoded p185 protein in primary lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2899%2900009-4

7 January 2021

p53: from molecular mechanisms to prognosis in cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2899%2900009-4

7 January 2021

The relationship of p53 immunostaining to survival in carcinoma of the lung

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2899%2900009-4

7 January 2021

Comparative analysis of p53 gene mutations and protein accumulation in human non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2899%2900009-4

7 January 2021

Expression of p53 oncoprotein in non-small-cell lung cancer: a favorable prognostic factor

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2899%2900009-4

7 January 2021

Nuclear p53 overexpression is an independent prognostic parameter in node-negative non-small cell lung carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2899%2900009-4

7 January 2021

Prognostic significance of p53 and ras p21 expression in nonsmall cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2899%2900009-4

7 January 2021

Immunohistochemical expression of the estrogen receptor-related antigen (ER-D5) in human intracranial tumors.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2899%2900009-4

7 January 2021

Immunohistochemical evaluation of P-glycoprotein in human malignancies by monoclonal antibody MC57.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2899%2900009-4

7 January 2021

Prognostic significance of the co-expression of p53 and c-erbB-2 proteins in breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2899%2900009-4

7 January 2021

Oncogene activation in chemical carcinogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2899%2900009-4

7 January 2021

Myc rescue of a mutant CSF-1 receptor impaired in mitogenic signalling

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2899%2900009-4

7 January 2021

10.1016/S0169-5002(99)00009-4

Identifiers

DOI

1 reference

19 May 2018

PubMed ID

10217618

1 reference

19 May 2018